| INTRODUC TI ON
For eligible patients with end-stage kidney disease, living donor kidney transplantation improves patient survival and quality of life and reduces healthcare costs compared to maintenance dialysis. [1] [2] [3] However, completing a living kidney donor evaluation according to current standards takes time and effort. 4 For many donor candidates and their intended recipients, the time to complete this evaluation is currently too long, which may have several unintended consequences for patients and the healthcare system. We have illustrated these consequences in Figure 1 for different types of recipients, where the dark horizontal bars represent current living kidney donor candidate evaluation times from start (subscript s) to finish (donation; subscript f). First, the potential recipient may no longer be able to receive a transplant due to illness or death ( Figure 1 , patient a f ). [5] [6] [7] [8] [9] Second, the recipient may remain on dialysis longer than otherwise necessary, which may result in adverse outcomes following transplantation, reduced quality of life, ongoing risk of complications related to dialysis, and higher healthcare costs ( Figure 1 , patient b f ). 10, 11 Third, the recipient may initiate dialysis before their donor is approved, potentially jeopardizing the benefits of pre-emptive transplantation, reducing quality of life and increasing healthcare costs ( Figure 1 , patient c f ). 12 Finally, the recipient may receive a kidney from a deceased donor, an organ that could have gone to another recipient in need if the living donor transplant had been realized. In reality, the definition of an "efficient" evaluation is subject to interpretation. We believe that an efficient evaluation process is one that is completed in an appropriate time-frame (which may depend on the donor and recipient candidates' needs), achieves the best possible outcomes for donors and recipients, and prudently uses healthcare resources.
In this study, we explored the potential effects of an earlier living donor evaluation completion and donation date on recipient outcomes and healthcare costs attributable to potentially preventable dialysis. We used current observed outcomes from Ontario, Canada, as the "base case" scenario, and examined several "what if"
scenarios for comparison had the living donor transplant occurred earlier.
F I G U R E 1 Possible effects of a more efficient living donor evaluation (a'-d') for different types of potential recipients (a-d).
Subscript s indicates the start of the living kidney donor candidate evaluation and subscript f indicates when the evaluation is finished. Recipient "a" is receiving maintenance dialysis when the living donor candidate evaluation begins and dies during the evaluation without receiving a transplant. Recipient "b" is receiving maintenance dialysis when the donor candidate evaluation begins and receives a living donor transplant. Recipient "c" is not receiving maintenance dialysis and has a low estimated glomerular filtration rate when the donor candidate evaluation begins, starts maintenance dialysis during the evaluation, and receives a living donor transplant. Recipient "d" is not receiving maintenance dialysis and has a low estimated glomerular filtration rate when the living donor candidate evaluation begins and receives a living donor transplant at a time when they could have lived longer with their native kidneys prior to initiating maintenance dialysis. For each of the potential recipients (a to d) the period from subscript "s" to subscript "f" represents a current donor candidate evaluation time (dark horizontal bars); the period from subscript "s prime (s')" to "f prime (f')" represents a new shorter evaluative time (light horizontal bars). A more efficient living donor evaluation is completed in a shorter time and is better timed to promote optimal recipient outcomes (ie, avoid dialysis or minimize the time spent on dialysis). 
| Patient populations
All living donors in this study were Ontario residents for at least Figure 1 ).
12,14
Classifying the cohort in this way enabled the outcomes to be evaluated separately for each cohort (outcomes described below). Figure 1 ), was deemed no longer eligible for transplant, or received a deceased donor kidney transplant.
To be included, the living donor candidate must have had at least 3 months of active evaluation (with any lab tests performed after review of the initial medical-social questionnaire 
| Outcomes
This study was undertaken from the perspective of the Ontario government, which operates under a single-payer universal public healthcare system. Outcome data were based on 4 domains:
time, pre-emptive transplantation, healthcare costs, and available additional kidneys for transplantation (summarized in Table 1 We devised 13 hypothetical scenarios (described below)
where the transplant date would occur at an earlier date than the actual transplant date. Using Figure 
; the length of dark horizontal bars minus the length of light horizontal bars in Figure 1 ]. The total time lost was calculated as a subset of the total time recovered, restricted only to donors who donated pre- Figure 1 ). This represents a lost period of survival only with native kidney function prior to initiating dialysis due to an earlier transplant. We calculated the dialysis time saved as a subset of the total time recovered, restricted only to donors who were already on dialysis when the evaluation started (b f -b f '
in Figure 1 ). We determined the number of recipients saved from starting dialysis as the difference in the number of pre-emptive transplants lost (patients whose evaluation times corresponded to category c f -c f ' in Figure 1 ). We estimated the total recipient dialysis costs saved as the differences in accrued dialysis costs over Figure 1 . Finally, we estimated the number of transplants gained as the difference in the number of transplants lost due to intended recipient death, loss of transplant eligibility, or receipt of a deceased donor kidney transplant.
For donor candidates who did not donate, we assumed that their evaluation would have been completed and that they would have donated in a time corresponding to each scenario's median total evaluation time.
| Scenarios
In scenarios 1-5, the time between consecutive healthcare visits related to the living donor evaluation process was changed, which is shown pictorially in Figure 2 . This was done using a longitudinal dataset with each healthcare visit for each donor on a separate row, sorted by date. 12 We used the 25th and 50th The distribution of some of these transition times is provided in Appendix 1.
We replaced the time between tests with a zero if 2 tests were to be modeled to occur on the same day (scenarios 3-5; Figure 2B ). In scenarios 7-10, we shifted the transplant date to occur 1, 2, 3, and 6 months earlier ( Figure 2C ). The resulting transplant dates reflect any combination of a quicker evaluation and/or an evaluation that simply started earlier. In a sensitivity analysis, the 3-month reduction in evaluation time was sampled from a gamma distribution (mean 3, SD 1) instead of being applied as a fixed value.
In scenarios 11-13, we determined the hypothetical transplant date resulting from a proportionate reduction in the total time to complete the evaluation (10%, 25%, and 50% faster), setting a minimum evaluation time of 3 months ( Figure 2D ). In sensitivity analysis, the 25% reduction in evaluation time was sampled from a probability distribution (beta [mean 0.25, SD 0.02]) instead of being applied as a fixed value.
| Costs
The ICES case-costing macro was used to tabulate recipient dialysis costs starting from April 1, 2006, which included various facility costs associated with dialysis treatment (ie, dialysate, vascular access, nursing F I G U R E 2 Altering the timeliness of the living kidney donor evaluation in hypothetical scenarios A Scenarios 1-2
The living donor evaluation was a proportion of its original length, and the transplant occurred immediately after this was completed (scenarios 11-13, respectively). The start of the evaluation does not change (e.g. ′ = ), but it ends earlier (e.g. ′ < ). In sensitivity analysis, the 25% reduction in evaluation time was sampled from a probability distribution [beta (mean 0.25, SD 0.02)] instead of being applied as a fixed value (Scenario 12a). 10, 25, or 90% of the evaluation time D Scenarios 11-13
The transplant occurred 1, 2, 3, or 6 months earlier (scenarios 7-10, respectively). This may correspond to a quicker living donor evaluation if the start of the evaluation does not change (e.g. ′ = ). This may also correspond to an earlier evaluation start (e.g. ′ < ) with or without a quicker evaluation. In sensitivity analysis, the 3-month reduction in evaluation time was sampled from a probability distribution [gamma (mean 3, SD 1)] instead of being applied as a fixed value (Scenario 9a).
1, 2, 3, or 6 months C Scenarios 7-10 time) from the National Ambulatory Care Reporting System (NACRS). 15 The macro uses resource intensity weights multiplied by the cost per weighted case to derive the cost per case for all healthcare in a hospital setting. 15 We combined these estimates with physician claim codes and dialysis facility costs to obtain a final estimate of recipient dialysis costs. 12 Costs were estimated from the perspective of the provincial government and presented in $CAD 2016. We did not assess the costs related to the donor evaluation or transplant surgery, as we expect these costs to remain the same, regardless of the timing of transplant (rather, the timing of the transplant will affect the costs by modifying the time on dialysis while waiting for the transplant to occur).
| RE SULTS

| Patient population
We used data on 877 living donors who began their evaluation after March 2006: 497 (57%) of recipients were already on dialysis when the living donor started the evaluation (cohort b s in Figure 1 ); 360 (41%) were potential pre-emptive transplants (cohorts c s +d s in Figure 1 ). We excluded 20 living donors (2%) who could not be clas-
sified (ie, valid linkage to recipient was not available). A total of 19
potential transplants lost were identified from chart review over a 3-year period (6 corresponded to cohort a s in Figure 1 ; 13 received a deceased donor kidney transplant).
| The base case
The total time to complete the donor candidate evaluation was a me- 
| Scenarios
The mean time recovered, mean time lost, mean dialysis time saved, number of potential pre-emptive transplants saved, mean dialysis costs saved, and number of living donor transplants gained are presented in Table 2 for each scenario compared to the base case.
The most effective scenario (from our list) in terms of absolute gains (differences in outcomes) resulted when the transition times between all tests took on the value of the 25th percentile.
This resulted in a median total evaluation time of 2.2 months (a very optimistic scenario). More realistic scenarios reduced the total evaluation time by half (scenarios 2, 10, and 13). These scenarios saved a mean $22 000-$26 000 in recipient dialysis costs per recipient, pre- 
| D ISCUSS I ON
In this study, we project that a transplant occurring on average Reduce/increase all transition times to the first quartile (best-case scenario) , then we expect that X*8/3 transplants were lost over the 8-year study period. This was divided by 0.07 (7%) to extrapolate the total number of transplants lost over the study period in the entire province.
e Reduction was modeled by randomly drawing from a distribution to allow for random variability. The 3-month reduction was sampled from a gamma distribution parametrized with a mean of 3 months and a standard deviation of 1 month; the 25% reduction was modeled using a beta distribution with a mean 0.25 and standard deviation 0.02. The number of living donor transplants gained was not calculated due to small sample for sampling and extrapolation.
TA B L E 2 (Continued)
instance, if a transplant occurred on average only 3 months sooner,
we would expect at least $2.7M in cost savings in Ontario every year.
Furthermore, avoiding or shortening dialysis time for recipients is expected to improve recipient health outcomes. Thus, there is much to be gained from improving the efficiency of the living kidney donor candidate evaluation process beyond prompting earlier recipient referrals, both of which have been recognized as significant barriers to optimal living donor kidney transplantation. 3, 12, 14, 18, 19 Where possible, pre-emptive kidney transplantation is the best treatment option for many patients with failing kidneys. Over the last decade, the proportion of kidney transplants that were pre- Another issue is the possible incentive that some for-profit dialysis facilities may enjoy by continuing to treat patients with dialysis. [31] [32] [33] [34] Although this situation is absent in a Canadian setting where there is universal healthcare, there are additional complexities that may exist even after a transplant referral occurs. 35, 36 Finally, the wait time to see a nephrologist in Canada can range from 2-8 months. [37] [38] [39] This wait time may be longer for living donor candidates, who are essentially seeking an elective procedure (not urgent).
Although we used real data in our models and our conclusions are Given the nature of this study, we had to make several assumptions that may limit the accuracy of the estimates. First, the date the donor started the evaluation was obtained by proxy using healthcare services utilized over a 4-year time-frame before donation. Figure 1 ), or who received a deceased donor transplant after the living donors' evaluation started. To supplement our study data, we conducted a detailed medical chart review for all donor candidates who contacted one living donor transplant program in Ontario. Although we used medical chart review on all donor candidates at this center to extrapolate the findings to the entire province, the number of events were small. We also assumed these estimates were generalizable, did not change over the study period, and that all candidates would have donated. Finally, the cost savings and improvement in outcomes presented in this report are likely underestimates because reductions in morbidity attributable to chronic kidney disease and dialysis are difficult to estimate (ie, infection, hyperparathyroidism, anemia, hospitalizations, and procedural-related complications).
In conclusion, a more efficient living kidney donor evaluation process is expected to result in better recipient outcomes, more living donor transplants, and substantial cost-savings to the healthcare system. 3, 40 A small reduction in the waiting time to receive a transplant can have a large impact on the number of pre-emptive transplants gained and total recipient dialysis costs saved. This vitally important healthcare process will benefit from quality improvement efforts. 
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